In light of the correlation between heightened YAP/TAZ levels and various types of cancer, therapeutic approaches aimed at combating cancer by targeting the Hippo pathway focus on directly or indirectly impeding the actions and roles of YAP and TAZ [15]. Here, YAP1 is linked to cancer.